Phio Pharmaceuticals - Warrants (21/12/2021) PEG Ratio

The latest PEG ratio for PHIOW is -0.84. That is below the Healthcare sector average of 3.22. Investors often review this figure alongside Phio Pharmaceuticals - Warrants (21/12/2021)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, PHIOW currently prints -0.84 for PEG ratio, while the sector average sits near 3.22. That is roughly 126.2% below the sector mean. Large gaps often invite a closer look at Phio Pharmaceuticals - Warrants (21/12/2021)'s growth, margins, and balance sheet.

A PEG ratio of -0.84 for Phio Pharmaceuticals - Warrants (21/12/2021) is not 'good' or 'bad' on its own. Compare it with the peer average (3.22) and with PHIOW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting PHIOW's PEG ratio (-0.84), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Phio Pharmaceuticals - Warrants (21/12/2021)'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.